Biologics Approved In 2013
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA transferred review of most therapeutic biologics to the Center for Drug Evaluation & Research in 2003. The Center for Biologics Evaluation & Research continues to review other biologics, including vaccines, cellular products, antitoxins and immunoglobulins.